Clinical trial NCT02001740: An RCT in Treatment of Adhesive Capsulitis Arthrographic Joint Distention With Local Anesthetic Alone
Official title: Treatment of Adhesive Capsulitis: A Randomized Placebo-Controlled Trial Comparing Arthrographic Joint Distention With Steroid and Local Anesthetic Versus Arthrographic Joint Distention With Local Anesthetic Alone
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: PHASE4
Conditions: Adhesive Capsulitis
Keywords: shoulder
Lead sponsor: Queen's University
Sponsor class: OTHER
First posted: 2013-12-05
Enrollment: 108
Sex: ALL
Minimum age (years): 19
Maximum age (years): 70
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Frozen shoulder or adhesive capsulitis is a common cause of shoulder pain, estimated to affect 25% of the general population. Many forms of treatment have been advocated for frozen shoulder including physiotherapy, injection with steroid, distension arthrogram with steroid, manipulation under anesthetic and arthroscopic releases. There is no general agreement in favour of one form of treatment, and the response to a particular treatment varies in different series. A few randomized controlled trials appear in the literature. Most of these showed improvements with steroid use, but the results were not always statistically significant. One randomized control trial reported superior results in favor of arthrographic joint distension with steroid compared to a saline placebo. To our knowledge there have been no other similar randomized trials to support these results. The objective of this study is to determine if arthrographic distension of the shoulder joint with steriods is an effective treatment modality for adhesive capsulitis as compared to injection with local anesthetic and contrast alone. The study design is a placebo-controlled, double blind clinical trial where participants will undergo distension arthrogram of the shoulder and be randomized to receive either Triamcinalone (steroid), lidocaine and contrast or injection with lidocaine and contrast alone.


Eligibility criteria: Inclusion Criteria:

* Age range 19-70
* Female and male
* Ability to understand and give consent
* Diagnosis of adhesive capsulitis (frozen shoulder) pain and stiffness for at least 3 months.

Exclusion Criteria:

* • Frozen shoulder secondary to trauma

  * Previous surgery on the affected shoulder
  * Age less than 19 or greater than 70
  * Systemic inflammatory joint disease such as Rheumatoid Arthritis
  * Radiographic evidence of osteoarthritis of the shoulder
  * Allergy to contrast material
  * Pregnant or breastfeeding women

Primary outcomes:
measure: functional outcomes as determined by the SPADI
timeFrame: change in baseline at 1 year.
Secondary outcomes:
measure: passive range of motion
timeFrame: baseline, 3 and 6 and 12 week post injection.
Other outcomes:
Locations:
city: Kingston
country: Canada
facility: Kingston General and Hotel Dieu Hospitals
state: Ontario
Study officials:
affiliation: Queen's University and Kingston General Hospital
name: Ryan Bicknell, MD
role: PRINCIPAL_INVESTIGATOR
References: